Larvol Delta - The-US-Food-and-Drug-Administration-today-approved-an-expanded-use-for-Auvelity-dextromethorphan-hydrobromide-and-bupropion-hydrochloride-extendedrelease-tablets-to-treat-agitation-associated-with-dementia-due-to-Alzheimers-disease-in-adults

Auvelity (bupropion/dextromethorphan) - Axsome Therap

https://www.fda.gov/news-events/press-announcements/fda-approves-first-non-antipsychotic-drug-treat-agitation-associated-dementia

Apr 30, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next